Grant of 2025 LTIP Awards

Summary by AI BETAClose X

Directa Plus plc has announced the grant of 3,758,943 nominal cost share options under its Long-Term Incentive Plan to key management and Executive Directors. These options will vest no earlier than three years from the grant date, contingent on the company's share price performance and achieving EBITDA positive status. The Chief Executive Officer received 1,754,385 awards, and the Chief Financial Officer received 744,284 awards.

Disclaimer*

Directa Plus PLC
15 December 2025
 

15 December 2025

 

Directa Plus plc

("Directa Plus", the "Company" or the "Group")

 

Grant of 2025 LTIP Awards

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene-based products for use in consumer and industrial markets, announces that the Company's Remuneration Committee has approved a grant of nominal cost share options to its key management and Executive Directors under its Long-Term Incentive Plan ("LTIP").

 

The LTIP is comprised of a total of 3,758,943 nominal cost share options over ordinary shares ("Awards") in the Company, which will become exercisable no earlier than three years from the date of grant, subject to satisfaction of criteria related to the Company's share price performance and the Company becoming EBITDA positive.

 

The Awards have been granted to the executive directors as follows.

 

Director

Role

Number of Performance Awards

Giulio Cesareo

Chief Executive Officer

1,754,385

Giorgio Bonfanti

Chief Financial Officer

744,284

 

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO


Giorgio Bonfanti, CFO




Singer Capital Markets

+44 20 7496 3069

Rick Thompson

Phil Davies




Alma Strategic Communications

+44 20 3405 0205

Justine James

Hannah Campbell

Rose Docherty

directaplus@almastrategic.com

 

About Directa Plus

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and past

 

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products. Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+®) have multiple applications due to its properties. These G+® products can be categorised into various families, with different products being suitable for specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. The Company holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings